Yes, companies that comply with the 2014 Farm Bill and its 2018 update can ship their products anywhere in the United States. The 2014 bill differentiates marijuana from industrial hemp and permits the cultivation of hemp within the United States, and the 2018 version reaffirms this distinction in more concrete terms that distinguish industrial hemp as an agricultural commodity.
In a study with HIV-positive adult men, blood concentrations of ghrelin and other appetitive hormones (leptin, PYY, and insulin) were tested after having received smoked medicinal cannabis or matched placebo for HIV-associated neuropathic pain. Cannabis administration, as compared to placebo, significantly increased ghrelin concentrations in this study. In addition, leptin and PYY levels were, respectively, increased and decreased, but no impact on insulin levels was found (Riggs et al., 2012).
Common adverse events (AE) of Sativex acutely in RCTs have included complaints of bad taste, oral stinging, dry mouth, dizziness, nausea or fatigue, but do not generally necessitate discontinuation, and prove less common over time. While there have been no head-to-head comparative RCTs of Sativex with other cannabinoid agents, certain contrasts can be drawn. Sativex (Rog et al 2005) and Marinol (Svendsen et al 2004) have both been examined in treatment of central neuropathic pain in MS, with comparable results (Table 1). However, adverse events were comparable or greater with Marinol than with Sativex employing THC dosages some 2.5 times higher due to the presence of accompanying CBD (Russo 2006b; Russo and Guy 2006).
Though clinical and anecdotal evidence suggests CBD’s benefits in managing different conditions, it became most famous for treating a rare and debilitating form of pediatric epilepsy. Dravet’s Syndrome is notoriously resistant to current approved treatment methods. Sufferers are plagued by seizures, often up to hundreds a day, that worsen as they age and can be life-threatening. Currently, treatment methods include having the child wear an eyepatch, specialized diets, and brain surgery, but all have mixed success rates.
Overall, researchers agree that while there isn’t conclusive data to support CBD oil as the preferred method of pain management, these types of products have a lot of potential. CBD products might be able to offer relief for many people who have chronic pain, all without causing intoxication and dependence. Oil versions of CBD may not be as effective as other forms, and more human studies are needed.
Pure hemp cannabidiol oil can be consumed directly as a nutritional supplement. Over the years, great advances in CBD hemp oil product development have led to what are now dozens of different types of CBD hemp oil products, including capsules, drops, and even chewing gum. Concentrated pure CBD hemp oil can also be infused into skin and body care products and used topically.
Cannabis, a drug prepared from the plant Cannabis sativa (including marijuana, resin, and “skunk”), is used widely throughout the world and is especially popular in North America, Western Europe, West and Central Africa, and Oceania (United Nations Office on Drugs and Crime, 2009). Several studies within the past decade have investigated the effect of continuous use of cannabis on psychotic illnesses, specifically schizophrenia. Zammit, Allebeck, Andreasson, Lundberg, and Lewis (2002) in Sweden found that those who smoked cannabis had a twofold increased risk of developing schizophrenia within 15 years. In addition, the researchers also found a dose–response relationship; subjects who used cannabis more heavily (over 50 reported occasions) were six times as likely to develop schizophrenia compared to those who did not use cannabis at all.
Doctors advise pregnant women not to use any drugs because they might harm the growing fetus. Although one animal study has linked marijuana use to loss of the fetus very early in pregnancy, two studies in humans found no association between marijuana use and early pregnancy loss. More research is necessary to fully understand the effects of marijuana use on pregnancy.
According to the U.S. Department of Health and Human Services, 116 people died every-day from opioid-related drug overdoses in 2016. Forty percent of these deaths involved a prescription opioid and in 2017, the government declared the opioid crisis a public health emergency. Opioids are typically prescribed by health care providers as a way to manage and treat pain. But what if there was a better solution?
Distinguishing cannabis and hemp can be confusing, so let's make it simple. There are many varietals of Cannabis sativa, all of which have different amounts of THC and CBD. Cannabis sativa varietals that have more than 0.3 percent THC are commonly referred to as marijuana. Hemp is any varietal of Cannabis sativa that contains less than 0.3 percent THC.
Cannabis impairs psychomotor performance in a wide variety of tasks, such as motor coordination, divided attention, and operative tasks of many types; human performance on complex machinery can be impaired for as long as 24 hours after smoking as little as 20 mg of THC in cannabis; there is an increased risk of motor vehicle accidents among persons who drive when intoxicated by cannabis.
On November 6, 2012, the voters of Massachusetts approved Question 3, “An Initiative Petition for a Law for the Humanitarian Medical Use of Marijuana,” by 63 percent establishing legal protection for medical cannabis patients, caregivers, physicians and medical professionals, cultivators, and providers, some of which went into effect as of January 1, 2013.
Szaflarski explains that cannabis contains about 500 different compounds, some of which—including CBD and THC—interact with certain chemical receptors in the human nervous system. But unlike THC, CBD isn’t psychoactive—meaning it doesn’t cause any kind of a high. Despite that, the US Drug Enforcement Agency classifies CBD (and other cannabis compounds) as schedule I substances, making their sale illegal in many states.
When elected to the presidency of the RACGP he said, “I will be passionate and vocal in advocating for primary healthcare and look forward to the challenge ahead”. Dr Seidel we hope that you can rise to the challenge of introducing Medicinal Cannabis to the mainstream of General Practice through education and encouragement of your peers. We strongly welcome you and thank you for your participation at this symposium.
The anti-inflammatory contributions of THC are also extensive, including inhibition of PGE-2 synthesis (Burstein et al 1973), decreased platelet aggregation (Schaefer et al 1979), and stimulation of lipooxygenase (Fimiani et al 1999). THC has twenty times the anti-inflammatory potency of aspirin and twice that of hydrocortisone (Evans 1991), but in contrast to all nonsteroidal anti-inflammatory drugs (NSAIDs), demonstrates no cyclo-oxygenase (COX) inhibition at physiological concentrations (Stott et al 2005a).
The other 29 states that fully legalize the Medical use of all CBD products derived from either hemp or Marijuana are: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Vermont, Washington and West Virginia. The territories of Guam and Puerto Rico also allow the use of CBD products on medical grounds.